Unveiling the Gut-Brain Axis: Fusobacteriaceae Promotes Parkinson’s Disease Development via CA9 Suppression-Induced Ferroptosis

IF 2.4 4区 医学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Ren Zihan, Li Pengfei, Cao Jingsi
{"title":"Unveiling the Gut-Brain Axis: Fusobacteriaceae Promotes Parkinson’s Disease Development via CA9 Suppression-Induced Ferroptosis","authors":"Ren Zihan,&nbsp;Li Pengfei,&nbsp;Cao Jingsi","doi":"10.1007/s12031-026-02530-z","DOIUrl":null,"url":null,"abstract":"<div><p>The conceptual framework of the ‘gut-brain axis’ proposes that an imbalance in the gut microbiota plays a contributory role in the etiology of Parkinson’s disease (PD). However, the specific molecular mechanisms, particularly those involving ferroptosis, remain largely unknown. We adopted a robust two-sample Mendelian randomization (MR) strategy, analyzing extensive summary-level GWAS data to unravel the causal connections tying the gut microbiota and ferroptosis-associated proteins to the risk of PD. Our analysis pinpointed 22 distinct gut microbial taxa and five proteins involved in ferroptosis that are genetically predicted to influence PD susceptibility. Notably, the family <i>Fusobacteriaceae</i> was identified as a robust risk factor. Further mediation analysis suggested that the ferroptosis-related protein carbonic anhydrase 9 (CA9) mediates the genetically predicted effect of <i>Fusobacteriaceae</i> on PD. Specifically, an elevated genetic predisposition to <i>Fusobacteriaceae</i> is associated with a downregulation of plasma CA9, a molecular shift that is genetically predicted to heighten the risk of developing PD. The calculated mediation proportion was 11.7%, and the robustness of this result was upheld by comprehensive sensitivity assessments. This study provides novel genetic evidence supporting a potential “gut microbiota–ferroptosis–PD” axis. We propose that <i>Fusobacteriaceae</i> may aggravate PD progression by downregulating CA9, thereby compromising CA9-dependent anti-ferroptotic defense mechanisms. Collectively, our results provide fresh perspectives on the molecular mechanisms underpinning the gut-brain axis, highlighting promising avenues for therapeutic intervention in PD. </p><h3>Graphical Abstract</h3><p>The proposed Fusobacteriaceae-CA9-Ferroptosis axis in Parkinson’s disease pathogenesis. A genetically predicted overabundance of Fusobacteriaceae compromises intestinal barrier integrity, facilitating the systemic translocation of lipopolysaccharides (LPS). Upon crossing the blood-brain barrier (BBB), circulating LPS triggers microglial activation and the sustained release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β). This chronic neuroinflammatory microenvironment represses the transcription and expression of the pH-regulating protein carbonic anhydrase 9 (CA9) in dopaminergic neurons. The subsequent CA9 downregulation induces severe intracellular acidification, which dualistically expands the labile iron pool (LIP) via ferritin degradation and cripples the antioxidant defense system by depleting glutathione (GSH) and inactivating GPX4. Ultimately, the confluence of elevated ferrous iron (Fe²⁺) and an acidic milieu aggressively accelerates the Fenton reaction, driving massive lipid peroxidation of polyunsaturated fatty acids (PUFAs) and culminating in neuronal ferroptosis</p><div><figure><div><div><picture><source><img></source></picture><span>The alternative text for this image may have been generated using AI.</span></div></div></figure></div></div>","PeriodicalId":652,"journal":{"name":"Journal of Molecular Neuroscience","volume":"76 2","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2026-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Molecular Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://link.springer.com/article/10.1007/s12031-026-02530-z","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The conceptual framework of the ‘gut-brain axis’ proposes that an imbalance in the gut microbiota plays a contributory role in the etiology of Parkinson’s disease (PD). However, the specific molecular mechanisms, particularly those involving ferroptosis, remain largely unknown. We adopted a robust two-sample Mendelian randomization (MR) strategy, analyzing extensive summary-level GWAS data to unravel the causal connections tying the gut microbiota and ferroptosis-associated proteins to the risk of PD. Our analysis pinpointed 22 distinct gut microbial taxa and five proteins involved in ferroptosis that are genetically predicted to influence PD susceptibility. Notably, the family Fusobacteriaceae was identified as a robust risk factor. Further mediation analysis suggested that the ferroptosis-related protein carbonic anhydrase 9 (CA9) mediates the genetically predicted effect of Fusobacteriaceae on PD. Specifically, an elevated genetic predisposition to Fusobacteriaceae is associated with a downregulation of plasma CA9, a molecular shift that is genetically predicted to heighten the risk of developing PD. The calculated mediation proportion was 11.7%, and the robustness of this result was upheld by comprehensive sensitivity assessments. This study provides novel genetic evidence supporting a potential “gut microbiota–ferroptosis–PD” axis. We propose that Fusobacteriaceae may aggravate PD progression by downregulating CA9, thereby compromising CA9-dependent anti-ferroptotic defense mechanisms. Collectively, our results provide fresh perspectives on the molecular mechanisms underpinning the gut-brain axis, highlighting promising avenues for therapeutic intervention in PD. 

Graphical Abstract

The proposed Fusobacteriaceae-CA9-Ferroptosis axis in Parkinson’s disease pathogenesis. A genetically predicted overabundance of Fusobacteriaceae compromises intestinal barrier integrity, facilitating the systemic translocation of lipopolysaccharides (LPS). Upon crossing the blood-brain barrier (BBB), circulating LPS triggers microglial activation and the sustained release of pro-inflammatory cytokines (e.g., TNF-α, IL-1β). This chronic neuroinflammatory microenvironment represses the transcription and expression of the pH-regulating protein carbonic anhydrase 9 (CA9) in dopaminergic neurons. The subsequent CA9 downregulation induces severe intracellular acidification, which dualistically expands the labile iron pool (LIP) via ferritin degradation and cripples the antioxidant defense system by depleting glutathione (GSH) and inactivating GPX4. Ultimately, the confluence of elevated ferrous iron (Fe²⁺) and an acidic milieu aggressively accelerates the Fenton reaction, driving massive lipid peroxidation of polyunsaturated fatty acids (PUFAs) and culminating in neuronal ferroptosis

The alternative text for this image may have been generated using AI.

Abstract Image

揭示肠脑轴:梭杆菌科通过CA9抑制诱导的铁下垂促进帕金森病的发展。
“肠脑轴”的概念框架提出,肠道微生物群的不平衡在帕金森病(PD)的病因学中起着重要作用。然而,具体的分子机制,特别是那些涉及铁下垂,仍然很大程度上是未知的。我们采用了稳健的双样本孟德尔随机化(MR)策略,分析了大量的汇总级GWAS数据,以揭示肠道微生物群和死铁相关蛋白与PD风险之间的因果关系。我们的分析确定了22种不同的肠道微生物分类群和5种与铁下垂有关的蛋白质,这些蛋白质在遗传上预测会影响PD的易感性。值得注意的是,梭杆菌科被确定为一个强大的危险因素。进一步的介导分析表明,与铁中毒相关的蛋白碳酸酐酶9 (CA9)介导了梭杆菌科对PD的遗传预测作用。具体来说,梭杆菌科的遗传易感性升高与血浆CA9的下调有关,这是一种分子转变,遗传预测会增加患PD的风险。计算出的中介比例为11.7%,综合敏感性评价维持了该结果的稳健性。这项研究提供了新的遗传学证据,支持潜在的“肠道微生物-嗜铁- pd”轴。我们认为梭杆菌科可能通过下调CA9来加剧PD的进展,从而破坏CA9依赖的抗铁致凋亡防御机制。总的来说,我们的结果为支持肠脑轴的分子机制提供了新的视角,突出了PD治疗干预的有希望的途径。图示:提出了梭杆菌- ca9 -铁下垂轴在帕金森病发病机制中的作用。一种基因预测的梭杆菌科的过量会损害肠道屏障的完整性,促进脂多糖(LPS)的系统性易位。在穿过血脑屏障(BBB)后,循环LPS触发小胶质细胞激活和促炎细胞因子(如TNF-α, IL-1β)的持续释放。这种慢性神经炎症微环境抑制多巴胺能神经元中ph调节蛋白碳酸酐酶9 (CA9)的转录和表达。随后的CA9下调诱导了严重的细胞内酸化,通过铁蛋白降解双重扩大了不稳定铁池(LIP),并通过消耗谷胱甘肽(GSH)和使GPX4失活来削弱抗氧化防御系统。最终,升高的亚铁(Fe 2 +)和酸性环境的融合积极地加速了芬顿反应,推动了多不饱和脂肪酸(PUFAs)的大量脂质过氧化,并最终导致神经元凋亡。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Molecular Neuroscience
Journal of Molecular Neuroscience 医学-神经科学
CiteScore
6.60
自引率
3.20%
发文量
142
审稿时长
1 months
期刊介绍: The Journal of Molecular Neuroscience is committed to the rapid publication of original findings that increase our understanding of the molecular structure, function, and development of the nervous system. The criteria for acceptance of manuscripts will be scientific excellence, originality, and relevance to the field of molecular neuroscience. Manuscripts with clinical relevance are especially encouraged since the journal seeks to provide a means for accelerating the progression of basic research findings toward clinical utilization. All experiments described in the Journal of Molecular Neuroscience that involve the use of animal or human subjects must have been approved by the appropriate institutional review committee and conform to accepted ethical standards.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书